STAA News and Press, STAAR Surgical Company From 11/01/23

2023-11-01 22:23:02 ET STAAR Surgical Company (STAA) Q3 2023 Earnings Conference Call November 01, 2023 04:30 PM ET Company Participants Brian Moore - Vice President-Investor Relations & Corporate Development Tom Frinzi - President & Chief Executive Officer ...

2023-11-01 16:04:24 ET More on STAAR Surgical STAAR Surgical: Not In My Sight Yet STAAR Surgical Company: The Stock Is Still An Eyesore STAAR Surgical: Economic Realities Beginning To Surface, Reiterate Hold STAAR Surgical Q3 2023 Earnings Preview Sta...

Net Sales of $80.3 Million; ICL Sales of $81.1 Million Up 13% Y/Y 23rd Consecutive Quarter of Double-Digit ICL Sales Growth 1 STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) fo...

Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...

STAAR Surgical Company (STAA) is expected to report $0.13 for Q3 2023

2023-10-24 12:28:24 ET Summary STAAR Surgical Company has developed the EVO ICL Lens to treat nearsightedness, offering clear vision without the hassle of contact lenses or glasses. The EVO ICL Lens has gained market share, with the EVO category capturing over 10% of the global ma...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the third quarter ended September 29, 2023 on Wednesday, November 1, 2023 after the market close. ...

ICL Corrects/Reduces Refractive Error for Glasses and Contact Lens Wearers 99.4% of Patients Surveyed Would Have ICL Procedure Again 1 STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrat...

Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL PR Newswire LAKE FOREST, Calif. , Oct. 10, 2023 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of impla...

2023-09-20 11:26:22 ET Summary EYE experienced weak sales performance and a decline in gross margin in 2Q, raising concerns about its growth potential and profit margins. The termination of its partnership with WMT adds uncertainty to its long-term growth prospects and will impact...